GRAIL is a healthcare company whose mission is to detect cancer early, when it can be cured. GRAIL is focused on alleviating the global burden of cancer by developing pioneering technology to detect & identify multiple deadly cancer types early. The company is using the power of next-generation sequencing, population-scale clinical studies, & state-of-the-art computer science & data science to enhance the scientific understanding of cancer biology, & to develop its multi-cancer early detection blood test. GRAIL is headquartered in Menlo Park, CA with locations in Washington, D.C., North Carolina, & the United Kingdom. GRAIL is a wholly-owned subsidiary of Illumina (NASDAQ:ILMN). For more information, please visit
www.grail.com.
Are you a dedicated scientist who wants to participate in the development of future Galleri product for detecting cancer early? We would love to talk to you about this great opportunity to work at our site in Menlo Park, California! GRAIL is seeking a detail oriented & data driven Associate Scientist for the R&D IVD product development team to contribute to the verification & validation (V&V) of assays for cancer early detection.
The successful candidate will be responsible for the planning & execution of experiments & data analysis with the mentorship of senior scientists. The ideal candidate is a meticulous, strong teammate with experience in next generation sequencing workflow & record keeping. Experience working on regulated products & under design control is important. The individual will enjoy working in the lab & have a desire to learn about developing products in a regulated environment.
